A detailed history of Nuveen Asset Management, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 554,588 shares of SANA stock, worth $3.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
554,588
Previous 728,034 23.82%
Holding current value
$3.22 Million
Previous $2.97 Million 86.7%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$4.2 - $11.27 $728,473 - $1.95 Million
-173,446 Reduced 23.82%
554,588 $5.55 Million
Q4 2023

Feb 14, 2024

SELL
$2.8 - $4.55 $121,533 - $197,492
-43,405 Reduced 5.63%
728,034 $2.97 Million
Q3 2023

Nov 14, 2023

SELL
$3.77 - $6.23 $5,074 - $8,385
-1,346 Reduced 0.17%
771,439 $2.99 Million
Q2 2023

Aug 14, 2023

SELL
$3.22 - $7.53 $23,473 - $54,893
-7,290 Reduced 0.93%
772,785 $4.61 Million
Q1 2023

May 15, 2023

BUY
$3.11 - $4.92 $172,449 - $272,814
55,450 Added 7.65%
780,075 $2.55 Million
Q4 2022

Feb 14, 2023

BUY
$3.19 - $6.46 $915,587 - $1.85 Million
287,018 Added 65.59%
724,625 $2.86 Million
Q3 2022

Nov 14, 2022

SELL
$5.58 - $9.04 $936,882 - $1.52 Million
-167,900 Reduced 27.73%
437,607 $2.63 Million
Q2 2022

Aug 15, 2022

BUY
$4.12 - $9.35 $962,184 - $2.18 Million
233,540 Added 62.79%
605,507 $3.89 Million
Q1 2022

May 16, 2022

BUY
$5.24 - $15.58 $617,209 - $1.84 Million
117,788 Added 46.34%
371,967 $2.55 Million
Q4 2021

Feb 14, 2022

SELL
$15.18 - $23.15 $2.69 Million - $4.11 Million
-177,405 Reduced 41.11%
254,179 $4.06 Million
Q3 2021

Nov 12, 2021

BUY
$16.29 - $25.88 $2.09 Million - $3.33 Million
128,606 Added 42.45%
431,584 $10.8 Million
Q2 2021

Aug 16, 2021

SELL
$16.65 - $32.14 $5.99 Million - $11.6 Million
-359,577 Reduced 54.27%
302,978 $5.96 Million
Q1 2021

May 17, 2021

BUY
$23.04 - $43.5 $15.3 Million - $28.8 Million
662,555 New
662,555 $22.2 Million

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $1.1B
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.